Detalhe da pesquisa
1.
Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3.
Graefes Arch Clin Exp Ophthalmol
; 261(3): 659-668, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36202933
2.
EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Retina
; 42(4): 721-729, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864802
3.
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy.
Graefes Arch Clin Exp Ophthalmol
; 259(4): 905-910, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119804
4.
RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Place Trial Report No. 4.
Retina
; 41(10): 2122-2131, 2021 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34543244
5.
Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy.
Graefes Arch Clin Exp Ophthalmol
; 258(6): 1191-1197, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32170365
6.
Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage.
Graefes Arch Clin Exp Ophthalmol
; 257(7): 1419-1425, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31123815
7.
Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.
Graefes Arch Clin Exp Ophthalmol
; 256(8): 1395-1402, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29732468
8.
Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial.
Am J Ophthalmol
; 233: 101-110, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214454
9.
Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients.
Ophthalmol Retina
; 6(10): 930-938, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470085
10.
Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence.
Sci Rep
; 11(1): 20446, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34650220
11.
Central serous chorioretinopathy in active endogenous Cushing's syndrome.
Sci Rep
; 11(1): 2748, 2021 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531597
12.
Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.
Acta Ophthalmol
; 99(7): 805-811, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33565230
13.
Photodynamic Therapy for Chorioretinal Diseases: A Practical Approach.
Ophthalmol Ther
; 9(2): 329-342, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279234
14.
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial.
Am J Ophthalmol
; 216: 80-89, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32289294
15.
Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.
Am J Ophthalmol
; 205: 1-10, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30951686
16.
Central serous chorioretinopathy: Towards an evidence-based treatment guideline.
Prog Retin Eye Res
; 73: 100770, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31319157
17.
Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy.
Clin Ophthalmol
; 12: 1061-1070, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29922035
18.
Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy.
PLoS One
; 13(8): e0202549, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142176
19.
Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy.
Clin Ophthalmol
; 12: 2167-2176, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30498331
20.
Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy.
Am J Ophthalmol
; 222: 397-398, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188739